Top 5 Wellness VC Funds in Taiwan
A list of 5 VC funds that invest in Wellness startups based in Taiwan. We rank investors based on the number of investments they made in Wellness companies from Taiwan. We update this investor list every month.Top 5 Wellness VC Funds in Taiwan
Investor | Wellness Taiwan investments |
---|---|
Panacea Venture | 1 |
Zero2IPO Ventures | 1 |
Guangzhou Yuexiu Industrial Investment Fund | 1 |
Suzhou Industrial Park Nankai Venture Capital | 1 |
Sino Biopharmaceutical | 1 |
Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Seed
- China, United States, Taiwan
Portfolio highlights
- Chime Biologics — Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stagebiopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.
- Base Therapeutics — Best Bio is a developer of cell therapy products and gene therapy products.
- Eos BioInnovation — We are dedicated to incubating, launching, and building early-stage companies emerging from leading academic labs and research institutions in regenerative medicine.
Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.
Show more
Investment focus
- E-Commerce, Internet, Education
- Series A, Series B, Angel
- China, India, Taiwan
Portfolio highlights
- AlpsenTek — AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Reistone Biopharma — Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global collaborations within Research and Development
Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Limited.
Show more
Investment focus
- Manufacturing, Health Care, Biotechnology
- Series B, Series C, Series A
- China, United States
Portfolio highlights
- EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
- Sonosemi Medical — Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.
- Chunqing Technology — Chunqing Technology is a company that create new generation of electric vehicles powered by alcohol and hydrogen. Chunqing Technology creates, manufactures, and distributes alcohol and hydrogen energy for the next generation of electric automobiles.
Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.
Show more
Investment focus
- Wellness, Health Care, Consumer Research
- Series A
- Taiwan
Portfolio highlights
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Series D, Series B, Series E
- China, United States, Israel
Portfolio highlights
- Medlinker — Medical Alliance is a post of physician social service platform. Users are certified doctors working in the Medical Alliance, they can share knowledge, experience and insights with the other industry elite, to continue to provide high quality content for each other. Application provides a medical quiz, map that case, the anonymous social circlesand doctors and other functions, is committed to helping physicians groups, more convenient access to high-quality information from the industry
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Generon (Shanghai) Corporation — Generon (Shanghai) Corporation Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide. Their research & development center is located in Zhang Jiang High-Tech Park, Shanghai, China. their cGMP drug manufacturing facility is located in Economic-Technological Development Area, Beijing, China. Theirmission is “Innovating for Life” to develop innovative therapeutic biologics for global patients with unmet medical needs. They employ their proprietary, cutting-edge technology platforms to discover, develop and manufacture biologic therapeutics. They are focused on “best-in-class” and “first-in-class” recombinant therapeutic proteins to treat cancer, autoimmune and inflammatory diseases. They follow international quality standards for their product development and adhere to regulatory requirements of the CFDA, FDA and EMA. “Innovation and quality” are the soul of Generon in the generation of scientific data and in the processes of drug discovery, development and manufacturing.
Investors by industry
Climate
Community
Gaming
Energy
FinTech
Impact
Biotech
Media (entertainment)
Hardware
Proptech
Marketplace
Artificial intelligence
Consumer
Health Care
EdTech
Sustainability
Agriculture (agtech)
Venture Capital
Photography
B2B
Infrastructure
Education
Food and Beverage
Payments
Video Games
Retail
Fashion
Finance
Publishing
Medical
Social Network
Wellness
Android
Social Media
Digital Media
Google
Mobile
Franchise
Music
Sports
Facebook
Legal
eSports
Local
Construction
Email
Enterprise Software
Internet
Art
Manufacturing
Travel
Recruiting
Cannabis
Biotechnology
Fitness
Platforms
Hospitality
Mobile Advertising
Medical Device
Automotive
Wine And Spirits
Crowdfunding
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
Clean Energy
LGBT
Financial Services
Big Data
Web3
Beauty
Oil and Gas
Real Estate
Organic Food
SaaS
Theatre
Film
Life Science
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Blockchain
Investors by country
South Korea
New Zealand
Germany
Ireland
United States
Australia
India
United Kingdom
Canada
Japan
Vietnam
Sri Lanka
China
Saudi Arabia
Middle East
Africa
Oceania
Asia
Europe
Indonesia
Singapore
Spain
Armenia
LATAM
Brazil
Qatar
South Africa
Georgia
Bahrain
Belize
Ethiopia
Bermuda
Chile
Costa Rica
France
Estonia
Kenya
Mexico
Morocco
Kazakhstan
Panama
Ghana
Kuwait
Cayman Islands
Liberia
Malta
Jersey
Liechtenstein
Norway
Peru
Israel
Malaysia
Mauritius
Lithuania
Mali
Philippines
Denmark
Nicaragua
Cambodia
Lebanon
Myanmar
Italy
Portugal
Thailand
Slovenia
Serbia
Sierra Leone
Rwanda
Poland
San Marino
Zimbabwe
Turkey
Seychelles
Tanzania
Sweden
Puerto Rico
Belarus
Taiwan
Uruguay
Senegal
Venezuela
El Salvador
Czech Republic
Zambia
Tunisia
Uzbekistan
Uganda
Russian Federation
Togo
Ukraine
Tajikistan
Dominican Republic
Ecuador
Egypt
Azerbaijan
Bahamas
Nigeria
Namibia
Iraq
Iceland
Croatia
United Arab Emirates
Honduras
Finland
Bolivia
Isle of Man
Hong Kong
Luxembourg
Pakistan
Algeria
Albania
Gibraltar
Faroe Islands
Greece
Hungary
Barbados
Bangladesh
Belgium
Argentina
Romania
Jordan
Grenada
Bulgaria
Austria
Oman
Cyprus
Latvia
Switzerland
Cameroon
Guatemala
Colombia
Marshall Islands
VC Funds in Taiwan by industry
Big Data
Financial Services
Cryptocurrency
Restaurants
Payments
Food and Beverage
Fashion
Manufacturing
Medical
Medical Device
Internet
Mobile
Software
Travel
Biotechnology
Enterprise
FinTech
Consumer
Biotech
Health Care
Hardware
EdTech
Climate
SaaS
Artificial intelligence
Media (entertainment)
Retail
Mobile Apps
Education
Web3
Community
Transportation
Social Media
Wellness
Blockchain
Impact
Marketplace
Energy
Sustainability
Gaming
Agriculture (agtech)